These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12843161

  • 1. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.
    Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ.
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3167-76. PubMed ID: 12843161
    [Abstract] [Full Text] [Related]

  • 2. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
    Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
    [Abstract] [Full Text] [Related]

  • 3. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC, Bray GA, Greeson CS, Klemperer M, Morris J, Partington C, Tulley R.
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
    [Abstract] [Full Text] [Related]

  • 4. Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study.
    Chung T, Kelleher S, Liu PY, Conway AJ, Kritharides L, Handelsman DJ.
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):235-45. PubMed ID: 17223994
    [Abstract] [Full Text] [Related]

  • 5. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
    Young NR, Baker HW, Liu G, Seeman E.
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
    [Abstract] [Full Text] [Related]

  • 6. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z, Blumsohn A, Mah PM, Meads DM, McKenna SP, Wylie K, Eastell R, Wu F, Ross RJ.
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [Abstract] [Full Text] [Related]

  • 7. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.
    Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A.
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):280-93. PubMed ID: 16117815
    [Abstract] [Full Text] [Related]

  • 8. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.
    Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):503-10. PubMed ID: 14764753
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
    Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT.
    JAMA; 2008 Jan 02; 299(1):39-52. PubMed ID: 18167405
    [Abstract] [Full Text] [Related]

  • 11. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
    Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T.
    J Am Soc Nephrol; 2006 Aug 02; 17(8):2307-14. PubMed ID: 16825332
    [Abstract] [Full Text] [Related]

  • 12. Testosterone therapy in glucocorticoid-treated men.
    Reid IR, Wattie DJ, Evans MC, Stapleton JP.
    Arch Intern Med; 1996 Jun 10; 156(11):1173-7. PubMed ID: 8639011
    [Abstract] [Full Text] [Related]

  • 13. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
    Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A.
    J Clin Endocrinol Metab; 2006 May 10; 91(5):1683-90. PubMed ID: 16478814
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study.
    Bouloux PM, Legros JJ, Elbers JM, Geurts TB, Kaspers MJ, Meehan AG, Meuleman EJ, Study 43203 Investigators.
    Aging Male; 2013 Jun 10; 16(2):38-47. PubMed ID: 23581697
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of models to predict anabolic response to testosterone administration in healthy young men.
    Woodhouse LJ, Reisz-Porszasz S, Javanbakht M, Storer TW, Lee M, Zerounian H, Bhasin S.
    Am J Physiol Endocrinol Metab; 2003 May 10; 284(5):E1009-17. PubMed ID: 12517741
    [Abstract] [Full Text] [Related]

  • 17. Effects of combined treatment with etidronate, nandrolone-decanoate and calcium on bone mineral density in postmenopausal women.
    Bolanca S, Korsić M, Dekanić D, Cvijetić S.
    Acta Med Croatica; 1998 May 10; 52(3):159-63. PubMed ID: 9818438
    [Abstract] [Full Text] [Related]

  • 18. Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial.
    Mok CC, Ying KY, To CH, Ho LY, Yu KL, Lee HK, Ma KM.
    Ann Rheum Dis; 2011 May 10; 70(5):778-84. PubMed ID: 21187295
    [Abstract] [Full Text] [Related]

  • 19. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
    Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK.
    J Clin Endocrinol Metab; 2001 May 10; 86(5):2020-6. PubMed ID: 11344201
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.
    Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ.
    J Clin Endocrinol Metab; 2001 Sep 10; 86(9):4078-88. PubMed ID: 11549629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.